Tag:
OrbusNeich
Latest Headlines
Latest Headlines
Data: OrbusNeich stent safe with DAPT
OrbusNeich's Genous stent is safe when accompanied by 10 days of dual antiplatelet therapy (DAPT), according to study data published in the November issue of EuroIntervention. In a multicenter trial
OrbusNeich releases data on combo stent, Genous
OrbusNeich was busy last week at the Transcatheter Cardiovascular Therapeutics 2011 conference in San Francisco. The company introduced the combo dual therapy stent and presented data showing its
